New

Wemedoo

The AI engine Fit Assessment

Beta

Wemedoo develops digital solutions that enhance clinical processes and operates within the pharmaceutical industry, particularly in oncology.

Blurb

Wemedoo is a clinical information specialist that offers clinical process engineering, data management, and technology solutions.

HQ Location

Steinhausen (Switzerland)

Founded

2020

Employees

51 - 200

Total funding raised

Not available

Funding Status

Non-Equity Assistance, August 29, 2024

Wemedoo is a clinical technology company built on deep clinical research expertise. We specialize in unified Clinical Research Information Systems (CRIS).



Our clinical trial software, oomnia, unifies Electronic Data Capture (EDC), Clinical Trial Management System (CTMS), electronic Trial Master File (eTMF), Randomization and Trial Supply Management (RTSM), electronic Informed Consent (eConsent), electronic Source (eSource), electronic Patient-Reported Outcomes (ePRO), and electronic Clinical Outcome Assessment (eCOA) into one interoperable solution.



By replacing fragmented platforms with a unified data model and shared governance layer, Wemedoo makes clinical research faster and smarter while ensuring 100% oversight, full data traceability, and continuous regulatory compliance at all times.



We support sponsors and CROs conducting clinical trials of any size, design, or geographic scope, from single-country and decentralized studies to large, global programs, all requiring structured data, inspection readiness, and complete operational control without system fragmentation.